300725 药石科技
2026/09 - 九个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.7783.9577.5457.19012.359
总资产报酬率 ROA (%)2.3672.9944.3743.9617.509
投入资产回报率 ROIC (%)2.5843.2094.7394.3068.452

边际利润分析
销售毛利率 (%)32.93130.81638.05542.51945.476
营业利润率 (%)10.63810.66014.87610.70018.606
息税前利润/营业总收入 (%)12.41512.12816.41515.97920.154
净利润/营业总收入 (%)9.2539.30613.00111.44020.436

收益指标分析
经营活动净收益/利润总额(%)100.39296.63399.102107.50692.302
价值变动净收益/利润总额(%)14.69817.80217.999-4.5054.523
营业外收支净额/利润总额(%)-1.596-1.384-0.92816.6128.216

偿债能力分析
流动比率 (X)3.6994.3033.6262.6683.598
速动比率 (X)2.7053.2492.5051.9822.683
资产负债率 (%)15.61414.16639.46544.50945.341
带息债务/全部投入资本 (%)2.2142.87632.50938.52038.414
股东权益/带息债务 (%)4,326.4443,166.512202.722155.374156.037
股东权益/负债合计 (%)540.436605.937153.387124.674120.552
利息保障倍数 (X)6.3857.5169.7955.077-171.427

营运能力分析
应收账款周转天数 (天)70.11378.693101.84583.86859.990
存货周转天数 (天)172.822197.049269.301254.331232.755